LU88603I2 - Trimetrexate glucuronate et ses dérivés pharmaceutiquement acceptables (NEUTREXIN R) - Google Patents

Trimetrexate glucuronate et ses dérivés pharmaceutiquement acceptables (NEUTREXIN R)

Info

Publication number: LU88603I2
Authority: LU; Luxembourg
Prior art keywords: neutrexin; pharmaceutically acceptable; acceptable derivatives; trimetrexate glucuronate; glucuronate
Prior art date: 1980-10-31

Application number

LU88603C

Other languages

English (en)

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-10-31

Filing date

1981-10-26

Publication date

1995-07-10

1981-10-26 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

1995-07-10 Publication of LU88603I2 publication Critical patent/LU88603I2/fr

Links

DQOGWKZQQBYYMW-LQGIGNHCSA-N 5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline-2,4-diamine;(2s,3s,4s,5r,6s)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O.COC1=C(OC)C(OC)=CC(NCC=2C(=C3C(N)=NC(N)=NC3=CC=2)C)=C1 DQOGWKZQQBYYMW-LQGIGNHCSA-N 0.000 title 2
229940063708 neutrexin Drugs 0.000 title 1
229960000538 trimetrexate glucuronate Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

LU88603C 1980-10-31 1981-10-26 Trimetrexate glucuronate et ses dérivés pharmaceutiquement acceptables (NEUTREXIN R) LU88603I2 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US20251280A	1980-10-31	1980-10-31

Publications (1)

Publication Number	Publication Date
LU88603I2 true LU88603I2 (fr)	1995-07-10

Family

ID=22750192

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU88603C LU88603I2 (fr)	1980-10-31	1981-10-26	Trimetrexate glucuronate et ses dérivés pharmaceutiquement acceptables (NEUTREXIN R)

Country Status (8)

Country	Link
EP (1)	EP0051415B1 (fr)
JP (1)	JPS5799574A (fr)
CY (1)	CY1416A (fr)
DE (1)	DE3167224D1 (fr)
HK (1)	HK17088A (fr)
LU (1)	LU88603I2 (fr)
NL (1)	NL950003I2 (fr)
SG (1)	SG92087G (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4670013A (en) *	1982-12-27	1987-06-02	Miles Laboratories, Inc.	Container for blood and blood components
ATE30344T1 (de) *	1983-10-26	1987-11-15	Schloetter Fa Dr Ing Max	Entmetallisierungsbad und verfahren zum elektrolytischen abziehen von metallen von titan als grundmetall.
US5716960A (en) *	1995-01-13	1998-02-10	U.S. Bioscience Inc. And Individuals	Crystalline trimetrexate salts and the process for making the same
US6017922A (en) *	1998-05-18	2000-01-25	U.S. Bioscience, Inc.	Thermally stable trimetrexates and processes for producing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1345502A (en) *	1972-07-06	1974-01-30	Parke Davis & Co	Quinazoline compounds and processes for their production

1981
- 1981-10-26 DE DE8181305027T patent/DE3167224D1/de not_active Expired
- 1981-10-26 EP EP81305027A patent/EP0051415B1/fr not_active Expired
- 1981-10-26 CY CY141681A patent/CY1416A/xx unknown
- 1981-10-26 JP JP56170264A patent/JPS5799574A/ja active Granted
- 1981-10-26 LU LU88603C patent/LU88603I2/fr unknown
1987
- 1987-10-19 SG SG920/87A patent/SG92087G/en unknown
1988
- 1988-03-03 HK HK170/88A patent/HK17088A/en not_active IP Right Cessation
1995
- 1995-03-17 NL NL950003C patent/NL950003I2/nl unknown

Also Published As

Publication number	Publication date
JPS5799574A (en)	1982-06-21
DE3167224D1 (en)	1984-12-20
SG92087G (en)	1988-05-06
NL950003I2 (nl)	1998-10-01
NL950003I1 (nl)	1995-05-01
CY1416A (en)	1988-04-22
JPH0438750B2 (fr)	1992-06-25
HK17088A (en)	1988-03-11
EP0051415A1 (fr)	1982-05-12
EP0051415B1 (fr)	1984-11-14

Similar Documents

Publication	Publication Date	Title
LU88736I2 (fr)	1996-08-23	Cefquinome et ses dérivés pharmaceutiquement acceptables (COBACTAN)
LU88750I2 (fr)	1996-08-23	VENLAFAXINE et ses dérivés pharmaceutiquement acceptables
LU91205I2 (fr)	2006-05-30	Ciclesonide et ses dérivés pharmaceutiquement acceptables (alvesco)
AU542659B2 (en)	1985-02-28	Oxazole derivatives and radiation-sensitive compositions
LU90951I2 (fr)	2003-01-15	Eurifel rcp felv et ses dérivés pharmaceutiquement acceptables
LU90829I2 (fr)	2001-11-12	Tepoxalin-zubrin et ses d-riv-s pharmaceutiquement acceptables
LU90037I2 (fr)	1997-06-13	Konakion et ses dérivés pharmaceutiquement acceptables
DK32982A (da)	1982-01-26	Terapeutisk nyttige tetralinderivater
JPS54145699A (en)	1979-11-14	133halo and 133deoxy derivative of cc076 compound
AU542544B2 (en)	1985-02-28	Tetrahydrophthalimide derivatives
FI813038L (fi)	1982-03-31	Derivater av kefalosporin foerfarande av framstaellning av dessa och sammansaettningar innehaollande dessa
AU8193082A (en)	1982-10-07	Tetrahydrophthalimides and their starting compounds
FI820397L (fi)	1982-08-10	Akrylat/maleatkopolymerer deras framstaellning och anvaendningmot bildning av pannsten
LU88790I2 (fr)	1997-03-18	Moxidectin et ses dérivés pharmaceutiquement acceptables
FI813037L (fi)	1982-03-31	Derivater av kefalosporin foerfarande av framstaellning av dessa och sammansaettningar innehaollande dessa
LU88843I2 (fr)	1997-03-14	Ropivacaine et ses dérivés pharmaceutiquement acceptables (Naropine R)
GB2078737B (en)	1984-03-14	Protection of arylmalonyl derivatives
LU88603I2 (fr)	1995-07-10	Trimetrexate glucuronate et ses dérivés pharmaceutiquement acceptables (NEUTREXIN R)
AU6733381A (en)	1981-09-10	3-0-demethyl derivatives of sannamycin c and
AU541724B2 (en)	1985-01-17	2-amino 4-pyrimidone derivatives
JPS53130699A (en)	1978-11-14	44deoxyvlbba and b and 33oxidized derivative of related 11formyl compound
SE7812832L (sv)	1979-06-22	2'-n-acyl och alkyl-6'-n-alkyl- och 6',6'-di-n-alkyl-derivat av fortimiciner a och b
AU538515B2 (en)	1984-08-16	Derivatives of 4-dihydropyridine substituted with benzoxadiazoles and benzothiadizoles
AU521715B2 (en)	1982-04-29	6 1 n-alkyl and 6 1, 5' din-alkyl derivatives of fortimycins aand b
LU88789I2 (fr)	1996-11-05	Mésylate de tirilazad et ses dérivés pharmaceutiquement acceptables (Freedox (R))